CCND2 and granular cell tumor: This is in line with our previous data demonstrating that mutated FOXL2 fails to interact with some of its pro-apoptotic partner which promotes cell viability [13], altogether indicating that mutation in FOXL2 gene gives the GCT cells a growth advantage, probably not directly through CCND2 regulation but by decreasing sensitivity to apoptosis.